The likelihood of regulatory delays as a consequence of the coronavirus outbreak is high, according to a recent poll conducted by Verdict.
A majority 62% of the poll respondents said that the delays are very likely, while 19% opined that the delays are ‘somewhat likely’.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Delays are unlikely, according to just 19% of the respondents.
The analysis is based on 679 responses received during the poll period from 26 March to 02 April.
The coronavirus outbreak is also expected to cause clinical trial delays, according to another poll run by Verdict during the same period.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
